Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
09/10/2026 10:55
BRIEF-Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study Oct 9 (Reuters) - Oncopeptides AB ONCO.ST:
CONFIRMS BLOOD-BRAIN-BARRIER PENETRATION BASED ON DATA FROM FIRST PATIENTS IN GLIOBLASTOMA WINDOW-OF-OPPORTUNITY STUDY
Source text: ID:nMFN8nd3g6
Further company coverage: ONCO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Oncopeptides AB
See all newsSweden's Oncopeptides Q3 net sales rise on Pepaxti demand
Brief: Oncopeptides Q3 Operating Profit SEK -36.47 Million
Brief: Oncopeptides Completes Directed Share Issue Of SEK 100 Mln
Brief: Oncopeptides Confirms Blood-Brain-Barrier Penetration In Glioblastoma Study
Swedish biotech Oncopeptides' Q2 net sales rise on strong demand in Italy